Inconsistency could only be derived for one closed loop (empagliflozin—licogliflozin—placebo) and did not reach statistical significance [IF 0.95, 95% confidence interval (CI) 0.00–4.92].
← all excerpts
Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis.
1
—
—